Tag Archives: Acting FDA Commissioner Janet Woodcock

Moderna COVID-19 Vaccine Gets Full FDA Approval

On Monday, the Food and Drug Administration (FDA) gave full approval to Moderna‘s COVID-19 vaccine for people 18 years of age and older. The approval makes it the second vaccine to be fully licensed in the United States. The vaccine will be marketed as Spikevax. Moderna’s messenger RNA vaccine has …

Read More »